These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 26980037)
1. ARID1A expression in early stage colorectal adenocarcinoma: an exploration of its prognostic significance. Lee LH; Sadot E; Ivelja S; Vakiani E; Hechtman JF; Sevinsky CJ; Klimstra DS; Ginty F; Shia J Hum Pathol; 2016 Jul; 53():97-104. PubMed ID: 26980037 [TBL] [Abstract][Full Text] [Related]
2. Switch/sucrose nonfermenting nucleosome complex-deficient colorectal carcinomas have distinct clinicopathologic features. Villatoro TM; Ma C; Pai RK Hum Pathol; 2020 May; 99():53-61. PubMed ID: 32222462 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancer. Wei XL; Wang DS; Xi SY; Wu WJ; Chen DL; Zeng ZL; Wang RY; Huang YX; Jin Y; Wang F; Qiu MZ; Luo HY; Zhang DS; Xu RH World J Gastroenterol; 2014 Dec; 20(48):18404-12. PubMed ID: 25561809 [TBL] [Abstract][Full Text] [Related]
4. Loss of ARID1A expression is associated with DNA mismatch repair protein deficiency and favorable prognosis in advanced stage surgically resected esophageal adenocarcinoma. Lowenthal BM; Nason KS; Pennathur A; Luketich JD; Pai RK; Davison JM; Ma C Hum Pathol; 2019 Dec; 94():1-10. PubMed ID: 31655170 [TBL] [Abstract][Full Text] [Related]
5. Various ARID1A expression patterns and their clinical significance in gastric cancers. Kim YB; Ham IH; Hur H; Lee D Hum Pathol; 2016 Mar; 49():61-70. PubMed ID: 26826411 [TBL] [Abstract][Full Text] [Related]
6. ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status. Inada R; Sekine S; Taniguchi H; Tsuda H; Katai H; Fujiwara T; Kushima R World J Gastroenterol; 2015 Feb; 21(7):2159-68. PubMed ID: 25717252 [TBL] [Abstract][Full Text] [Related]
7. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer. Korphaisarn K; Pongpaibul A; Limwongse C; Roothumnong E; Klaisuban W; Nimmannit A; Jinawath A; Akewanlop C World J Gastroenterol; 2015 Jan; 21(3):926-34. PubMed ID: 25624727 [TBL] [Abstract][Full Text] [Related]
8. Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency. Wang J; Andrici J; Sioson L; Clarkson A; Sheen A; Farzin M; Toon CW; Turchini J; Gill AJ Hum Pathol; 2016 Sep; 55():83-90. PubMed ID: 27184481 [TBL] [Abstract][Full Text] [Related]
9. Loss of ARID1A expression in colorectal carcinoma is strongly associated with mismatch repair deficiency. Chou A; Toon CW; Clarkson A; Sioson L; Houang M; Watson N; DeSilva K; Gill AJ Hum Pathol; 2014 Aug; 45(8):1697-703. PubMed ID: 24925223 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors with medullary histology and high TNM stage. Ye J; Zhou Y; Weiser MR; Gönen M; Zhang L; Samdani T; Bacares R; DeLair D; Ivelja S; Vakiani E; Klimstra DS; Soslow RA; Shia J Hum Pathol; 2014 Dec; 45(12):2430-6. PubMed ID: 25311944 [TBL] [Abstract][Full Text] [Related]
11. Loss of Hes1 expression is associated with poor prognosis in colorectal adenocarcinoma. Ahadi M; Andrici J; Sioson L; Sheen A; Clarkson A; Gill AJ Hum Pathol; 2016 Nov; 57():91-97. PubMed ID: 27476040 [TBL] [Abstract][Full Text] [Related]
12. DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma. González I; Goyal B; Xia MD; Pai RK; Ma C Hum Pathol; 2019 Mar; 85():18-26. PubMed ID: 30381262 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis. Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157 [TBL] [Abstract][Full Text] [Related]
14. SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer. Ma C; Olevian D; Miller C; Herbst C; Jayachandran P; Kozak MM; Chang DT; Pai RK Mod Pathol; 2019 Jul; 32(8):1217-1231. PubMed ID: 30962505 [TBL] [Abstract][Full Text] [Related]
15. Loss of stromal caveolin-1 expression in colorectal cancer predicts poor survival. Zhao Z; Han FH; Yang SB; Hua LX; Wu JH; Zhan WH World J Gastroenterol; 2015 Jan; 21(4):1140-7. PubMed ID: 25632186 [TBL] [Abstract][Full Text] [Related]
16. LSF expression and its prognostic implication in colorectal cancer. Jiang H; Du J; Jin J; Qi X; Pu Y; Fei B Int J Clin Exp Pathol; 2014; 7(9):6024-31. PubMed ID: 25337247 [TBL] [Abstract][Full Text] [Related]
18. Keratin 20 - a diagnostic and prognostic marker in colorectal cancer? Harbaum L; Pollheimer MJ; Kornprat P; Lindtner RA; Schlemmer A; Rehak P; Langner C Histol Histopathol; 2012 Mar; 27(3):347-56. PubMed ID: 22237712 [TBL] [Abstract][Full Text] [Related]
19. Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients. Bae JM; Lee TH; Cho NY; Kim TY; Kang GH World J Gastroenterol; 2015 Feb; 21(5):1457-67. PubMed ID: 25663765 [TBL] [Abstract][Full Text] [Related]
20. Combination of p53 expression and p21 loss has an independent prognostic impact on sporadic colorectal cancer. Noske A; Lipka S; Budczies J; Müller K; Loddenkemper C; Buhr HJ; Kruschewski M Oncol Rep; 2009 Jul; 22(1):3-9. PubMed ID: 19513497 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]